Supplied exclusively for research use, it supports structured experimental workflows focused on compound characterization, assay development, and reproducibility across laboratory studies
Similar to our previous study (Jing et al., 2022), all groups received once-daily oral dose of lenvatinib mesylate (2 mg/kg
This work was supported in part by a KAKENHI grant from the Japan Society for the Promotion of Science [grant numbers 23K13883] (M.M.) and the Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)) from AMED under Grant Number JP24ama121054 (M.A.)
Whitburn, J., Edwards, C
C., Ibi, A., Wood, S., Hardy, M., Gahler, R
Zinc may enhance nuclear factor erythroid 2-related factor(Nrf2) expression and promote the upstream active regulator, Phosphorylated-Akt (p-Akt) expression, showing that the Phosphoinositide 3-kinase(PI3K)-Akt/nuclear factor erythroid 2-related factor(Nrf2) pathway is associated with the zinc actions (150)